Are you worried about blood clots? I have some bad news for you about this virus that’s going around.

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM nejm.org/doi/full/10.10…

The complex situation for immunocompromised people and COVID-19 vaccines - National Geographic apple.news/A0KDSHJ_jTiyhU…

a major scientific breakthrough that happens once every decade or so businesswire.com/news/home/2022…

Honoring the giants on whom shoulders we stand at #IMS2022 Thank you Dr. Kyle! #mmsm

Dr. Bart Barlogie honored as a pioneer in the field of myeloma for his lifetime contributions. Myeloma Society Without him, there will be no thalidomide, Revlimid, or Pomalyst for myeloma. Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Mohamad Mohty Noopur Raje Tom Martin marivi mateos Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Shaji Kumar #IMS2022

Quote of the day from Dr Chiari, GPRC5D, BCMA CarT or bi specific they are all our children and we should love them equally. #mmsm #ASH22

Elranatamab from magnetism-1 presented by Noopur Raje - key updates are responses in patients with prior bcma-directed therapy (54%) and duration of response (17 months).

Cevostamab is the first bispecific to show durable results with fixed duration rather than continuous therapy. Median DOR is 11.1 months with median time on therapy 8.8 months. Infections are the “Achilles heel” of bispecifics. So longer intervals between doses is key! #ASH22

Attralus receives FDA and EMA orphan designation for AT-01 as a #diagnostic for the management of ATTR and AL #amyloidosis. Read more @ ow.ly/QrZ850M6Vsg.

Agree 💯! Regardless of ratio & IFE, elevated lambda > kappa: considered guilty until proven innocent! #lambdaparanoia Angela Dispenzieri Martha Grogan MD Taxiarchis Kourelis

🚨 Excited to share our work!! We describe the strengths and possible pitfalls of our AI-ECG for cardiac amyloidosis algorithm in this validation study🫀Thank you Martha Grogan MD Angela Dispenzieri for your support 🙏🏽 Mayo Clinic CV Mayo Clinic Rochester Cardiology Fellows #amyloidosis thank you! #JACCAdvances

For those of us lucky enough to be his mentees and colleagues it is not only the extent of academic achievement that deserves an award but the greatness in character. Shaji is the kindest, most humble and gracious person and we are lucky to work with him.

👏 Morie Gertz et al 👉Anti-amloid mAb Birtamimab improved all-cause mortality in Mayo stage IV AL amyloidosis with cardiac involvement 👉Birtamimab plus standard of care in light-chain amyloidosis: Phase 3 randomized placebo-controlled VITAL trial ashpublications.org/blood/article/…

Nice overview of history of amyloid by Morie Gertz also reminding us that academic teasing has been with us since the beginning of time (“bacon connoisseurs”🤭) #ISA2024 #amyloidosis

Important Markers of TTR-CA progression: 1. Decrease of 35 meters in 6-min walk test, 2. Increase in NT-proBNP and 3. Oral diuretics intensification . Great talk by Mat Maurer ! The International Society Of Amyloidosis Martha Grogan MD Ahmed Sami Abuzaid MD,EMHL,FACP,FASE,FESC,FACC Dra. Isabel Carvajal. Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 #ISA_2024

Lessons in heart tx by Ronald Witteles #isa2024 #hopeishere #amyloidosis #refer 👏👏 🫀outcomes MUCH improved 🫀time to tx in AL 🔑 🫀patient selection 🔑 ❓: 🫀Disease targeted tx post ATTR 🫀Balance of immuno tx & AL directed tx

And #ISA24 is a wrap with Shaji Kumar taking over as ISA Prez. A fantastic meeting (thanks Martha Grogan MD Morie Gertz Angela Dispenzieri) - great science, happy reunions w/ friends & colleagues, and plenty of inspiration as I had back home Medical College of Wisconsin. Until #ISA26 in Montevideo..

Heartfelt thanks to the organizers for a meticulously planned and well coordinated #ISA24 Martha Grogan MD Angela Dispenzieri Morie Gertz BU Amyloidosis Center The International Society Of Amyloidosis

#isa24 my thanks to everyone who made the difficult track to Rochester Minnesota. The high-quality scientific presentations really made the meeting resonate. I hope to see all of you in Uruguay.